Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
SCHEDULE OF OTHER CURRENT ASSETS

Other current assets consisted of the following as of March 31, 2023 and December 31, 2022:

 

    March 31, 2023     December 31, 2022  
Lab supplies   $ 1,174     $ 1,224  
Prepaid expenses     327       390  
Funds in escrow     500       500  
Other     172       180  
Total other current assets   $ 2,173     $ 2,294  
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE

 

    2023     2022  
    Three Months Ended  
    March 31,  
    2023     2022  
Basic weighted average number of common shares     4,307       4,208  
Potential dilutive effect of stock-based awards     1       -  
Diluted weighted average number of common shares     4,308       4,208  
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

  

    2023     2022  
    Three Months Ended  
    March 31,  
    2023     2022  
Options     526       641  
Restricted stock units (RSUs)     219       319  
Warrants     -       1,339  
Antidilutive securities excluded from computation of earnings per share     745       2,299